Heterozygous de novo variants in DENND5B with predicted loss of function have been associated with neurodevelopmental disorders with dysmorphic features and behavioral dysregulation (the latter including ASD, ADHD, and anxiety disorder) [25]. The gene discussed is DENND5B; the disease is attention deficit-hyperactivity disorder.